Wellington Management Group LLP cut its holdings in Trupanion, Inc. (NASDAQ:TRUP – Free Report) by 31.5% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 50,487 shares of the financial services provider’s stock after selling 23,268 shares during the period. Wellington Management Group LLP’s holdings in Trupanion were worth $1,251,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors also recently bought and sold shares of the business. Kelleher Financial Advisors purchased a new stake in Trupanion during the 2nd quarter worth about $42,000. Parallel Advisors LLC increased its holdings in shares of Trupanion by 1,831.9% in the 1st quarter. Parallel Advisors LLC now owns 1,816 shares of the financial services provider’s stock valued at $47,000 after acquiring an additional 1,722 shares during the last quarter. Kemnay Advisory Services Inc. acquired a new stake in shares of Trupanion during the 4th quarter worth about $64,000. Quantbot Technologies LP purchased a new stake in Trupanion during the second quarter worth approximately $89,000. Finally, Advisory Services Network LLC purchased a new stake in Trupanion during the third quarter worth approximately $160,000.
Trupanion Stock Performance
Shares of TRUP stock opened at $24.89 on Friday. Trupanion, Inc. has a 52-week low of $21.16 and a 52-week high of $46.98. The company has a quick ratio of 1.77, a current ratio of 1.77 and a debt-to-equity ratio of 0.24. The stock’s 50-day moving average price is $27.41 and its 200 day moving average price is $25.78. The stock has a market capitalization of $1.09 billion, a PE ratio of 46.96, a price-to-earnings-growth ratio of 1.69 and a beta of 1.45.
Analyst Ratings Changes
A number of research firms have weighed in on TRUP. Zacks Research cut shares of Trupanion from a “strong-buy” rating to a “hold” rating in a report on Monday, August 24th. Stifel Nicolaus upped their target price on shares of Trupanion from $28.00 to $29.00 and gave the company a “hold” rating in a report on Thursday, August 20th. Weiss Ratings downgraded shares of Trupanion from a “hold (c)” rating to a “hold (c-)” rating in a research report on Thursday. Piper Sandler lowered shares of Trupanion from an “overweight” rating to a “neutral” rating and cut their price target for the stock from $45.00 to $32.00 in a research note on Wednesday, August 26th. Finally, Atlantic Securities set a $42.00 price target on shares of Trupanion in a research report on Wednesday, July 15th. One research analyst has rated the stock with a Buy rating and five have issued a Hold rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $39.20.
Check Out Our Latest Stock Report on Trupanion
Insider Transactions at Trupanion
In other Trupanion news, CFO Fawwad Qureshi sold 6,111 shares of the stock in a transaction dated Wednesday, August 26th. The shares were sold at an average price of $30.01, for a total value of $183,391.11. Following the completion of the transaction, the chief financial officer directly owned 4,230 shares of the company’s stock, valued at approximately $126,942.30. This trade represents a 59.09% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CEO Margaret Tooth sold 978 shares of the business’s stock in a transaction that occurred on Tuesday, August 11th. The stock was sold at an average price of $29.05, for a total value of $28,410.90. Following the sale, the chief executive officer directly owned 175,401 shares in the company, valued at $5,095,399.05. This trade represents a 0.55% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders sold 12,046 shares of company stock valued at $356,210. Corporate insiders own 5.58% of the company’s stock.
Trupanion Company Profile
Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.
Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.
Recommended Stories
- Five stocks we like better than Trupanion
- Block Makes a Federal Trust Bank Move That Could Reshape Its Fintech Model
- Kroger’s Textbook Entry for Buy-and-Hold Investors
- AST SpaceMobile Looks to Extend Its 30-Day FCC Satellite Testing Window
- Amgen Drops 10% on a Trial It Didn’t Even Run
Want to see what other hedge funds are holding TRUP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Trupanion, Inc. (NASDAQ:TRUP – Free Report).
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.
